What CEOs needed to know this year, pursuing growth in today's financial landscape, and more make up our most popular episodes of our Radio Advisory podcast in 2023.

The 10 most popular Radio Advisory episodes of 2023

1. Part 1: What CEOs need to know in 2023

Healthcare leaders are entering the new year with an unusually high number of short-term crises – things like rising costs, increased competition, and staffing shortages. So where should you be focusing your attention in 2023?

In this episode host Rachel Woods talks with executive strategy experts Natalie Trebes and Aaron Mauck about the complexities of today’s market and what should be on a leaders' radar for 2023.

2. Pursuing growth in today's financial landscape

Factors like labor, supply costs, and rising costs of capital are making it harder than ever for leaders to develop and implement growth strategies and are showing no signs of letting up anytime soon.

In this episode, Rachel Woods invites healthcare strategy experts Colin Gelbaugh and Vidal Seegobin to discuss how health systems' growth strategies have shifted and what leaders can do to improve their organizations' trajectories, even if you're only in survival mode right now.

3. How consolidation and corporate ownership are reshaping the healthcare industry

Vertical integration and consolidation are significantly altering the healthcare landscape. From health plans to retailers to incumbent health systems, consolidation is reshaping conventional norms in the industry.

In this episode, host Rachel Woods speaks with Advisory Board experts Paul Trigonoplos and Eliza Dailey about the reasons for and reactions to the recent explosion in consolidation across the industry. Throughout the discussion, they explore how different stakeholders are responding, and where the future is heading for diversification and integration.

4. Ozempic, Wegovy, and our questions on weight management drugs

Demand – and concern – is growing for the newest generation of weight loss drugs. Approved by the FDA to treat type 2 diabetes, drugs like Ozempic and Wegovy have set off a media frenzy as celebrities and the wealthy touted their weight loss benefits. Leaders have a lot of questions about protocol, supply, and coverage of these drugs, and the consequences of patients using them for their unintended purpose.

In this episode, host Rachel Woods walks through these questions with experts Kara Marlatt, Gaby Marmolejos, and Chloe Bakst and discuss the potential future of weight management in U.S. healthcare.

5. Employer series: Is the cost of employer-sponsored insurance unsustainable?

While always facing a dynamic landscape, one of the biggest issues today in the employer-sponsored insurance market is affordability. As healthcare costs continue to rise, employers are getting increasingly nervous about their ability to pay for employees’ health insurance, especially in a time of heightened worker shortages.

In this episode, guest host and Advisory Board VP and spokesperson Aaron Mauck discusses employer market affordability with Advisory Board health plan experts Sally Kim and Max Hakanson. Throughout the conversation, they explore the context of the problem, root causes, and what the future may look like for employer-sponsored insurance.

6. The promise (and perils) of physician autonomy

Physicians have more options than ever before when it comes to employment as more organizations move to acquire practices. In this episode, host Rachel Woods talks with physician experts Eliza Dailey and Sarah Hostetter about the new era of physician employment, what it means for the rest of the industry, and striking the right balance between autonomy and integration.

7. Employer series: The role of employers in value-based care

In this episode, host Rachel Woods invites Advisory Board value-based care experts Daniel Kuzmanovich and Sophia Hurr to discuss the opportunity that value-based care presents for employers to reduce the costs of care while increasing the quality of care their employees receive.

Throughout the conversation, they explore what kinds of employers are best positioned to pursue value-based care, and the different paths to get there.

8. Build a value-based enterprise: Live from 2023 Value-Based Care Summit

While value-based care has been at the forefront of industry conversations in the last decade, there are still a lot of questions about how to successfully create and thrive as a value-based enterprise.

At the end of June, around 300 healthcare leaders gathered at Advisory Board's Value-Based Care Summit with one shared goal: make the next 10 years of VBC more impactful from the last. As part of the event, the Radio Advisory team orchestrated a live podcast recording with three renowned leaders at the helm of very different organizations — all trying to build value-based enterprises.

In this special live episode of Radio Advisory, host Rachel Woods invites Rob Mayer, SVP and GM of Optum Insight Clinical Solutions, Laurie Sicaeros, Chief Strategy Officer at Memorial Care Health System, and Rushika Fernandopulle, Co-Founder and Former CEO of Iora Health, to discuss building a value-based enterprise, what defines success, and what capabilities and assets are needed to succeed.

9. How nervous should we be about high-cost drugs?

With a variety of new (and expensive) therapies in the pipeline for 2023, it is understandable that the industry is feeling anxiety over the rise of high-cost drugs. However, there is not one-size-fits all solution. Industry stakeholders must consider and respond differently to each drug type.

In this episode, host Rachel Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to discuss how industry stakeholders are thinking about different high-cost drugs and how they can prepare for the future.

10. Innovative or invasive? How consumer data is changing healthcare

For years, consumers have felt the effects of the increased use of their data. From receiving targeted advertisements to personalized recommendations online, it is no secret that giants in various industries are taking advantage of complex consumer data. But how does this look in the healthcare space?

In part one of a three-part series on consumer data, host Rachel Woods invites Advisory Board experts Solomon Banjo and Ty Aderhold to discuss how various industry players are taking advantage and navigating the challenges of the use of consumer data in healthcare.

In the conversation, they explore exactly what kind of information is being used, what this means for various stakeholders, and how the rising use of consumer health data is poised to radically change the industry.